bpc-157 human studies clinical trials safety review The Stable Gastric Pentadecapeptide BPC 157 Pleiotropic Beneficial Activity and Its Possible Relations with Neurotransmitter Activity How does the peptide BPC-157
Description
Start feeling the shift within weeks
CoA-LOT: BN20231015/CA
Adults Over 50 Reduced stomach acid production Decreased ability to absorb B12 from food Common medications that interfere with B12 absorption 4
No Impact on IGF-1 or Blood Sugar Levels Unlike full growth hormone therapy, which can increase IGF-1 and affect glucose metabolism, AOD-9604: Does not elevate IGF-1 levels, reducing the risk of unwanted anabolic effects or organ enlargement
